Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Mina

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
JCO Oncology Practice|December 11, 2025
Facing DeathAlain Mina
Leukemia & Lymphoma|December 2, 2024
Targeted therapy in acute T-cell leukemia/lymphoma: are we close?Alain Mina
Blood|January 14, 2025
How I treat higher-risk MDSAlain Mina, Rami Komrokji
Blood Reviews|October 30, 2021
T time: Emerging and new therapies for peripheral T-cell lymphomaAlain Mina, Barbara Pro
Journal of Comparative Effectiveness Research|January 30, 2020
Use of hyperbaric oxygen in hematopoietic cell transplantation to aid post-transplant recoveryAlain Mina, Omar S Aljitawi
Expert Opinion on Pharmacotherapy|March 10, 2026
Pharmacologic progress in higher-risk MDS: an uphill battleAlain Mina, Amer M Zeidan
Leukemia & Lymphoma|August 12, 2020
Increasing megakaryopoiesis without promoting the malignant clone in myeloid malignanciesAlain Mina, Leonidas C Platanias
Chinese Clinical Oncology|May 18, 2026
Targeting metabolism in acute myeloid leukemia: the next therapeutic frontier?Alain Mina, Amer M Zeidan
Oncotargets and Therapy|October 17, 2017
Targeting the androgen receptor in triple-negative breast cancer: current perspectivesAlain Mina, Rachel Yoder, Priyanka Sharma
Cancers|August 29, 2024
Breaking Boundaries: Immunotherapy for Myeloid MalignanciesTatyana Gavrilova, Eduard Schulz, Alain Mina
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
JCO Oncology Practice|December 11, 2025
Facing DeathAlain Mina
Leukemia & Lymphoma|December 2, 2024
Targeted therapy in acute T-cell leukemia/lymphoma: are we close?Alain Mina
Blood|January 14, 2025
How I treat higher-risk MDSAlain Mina, Rami Komrokji
Blood Reviews|October 30, 2021
T time: Emerging and new therapies for peripheral T-cell lymphomaAlain Mina, Barbara Pro
Journal of Comparative Effectiveness Research|January 30, 2020
Use of hyperbaric oxygen in hematopoietic cell transplantation to aid post-transplant recoveryAlain Mina, Omar S Aljitawi
Expert Opinion on Pharmacotherapy|March 10, 2026
Pharmacologic progress in higher-risk MDS: an uphill battleAlain Mina, Amer M Zeidan
Leukemia & Lymphoma|August 12, 2020
Increasing megakaryopoiesis without promoting the malignant clone in myeloid malignanciesAlain Mina, Leonidas C Platanias
Chinese Clinical Oncology|May 18, 2026
Targeting metabolism in acute myeloid leukemia: the next therapeutic frontier?Alain Mina, Amer M Zeidan
Oncotargets and Therapy|October 17, 2017
Targeting the androgen receptor in triple-negative breast cancer: current perspectivesAlain Mina, Rachel Yoder, Priyanka Sharma
Cancers|August 29, 2024
Breaking Boundaries: Immunotherapy for Myeloid MalignanciesTatyana Gavrilova, Eduard Schulz, Alain Mina
Pageof 5